Clinical Lymphoma, Myeloma & Leukemia
Publisher: Elsevier · ISSN 2152-2650 · 71 articles
- Blastic Plasmacytoid Dendritic Cell Neoplasm in the Dual CD123-targeted Therapy Era: A Clinical Decision Review of Treatment Selection, Sequencing, CNS Management, and Transplant Integration
- Efficacy and Safety of Azacitidine in Patients With RUNX1::RUNX1T1 Measurable Residual Disease-Positive Acute Myeloid Leukemia After Consolidation Therapy Who Did Not Undergo Allogeneic Hematopoietic Stem-Cell Transplantation
- Supportive Care in Multiple Myeloma: Evidence-Based Recommendations From the Intergroupe Francophone du Myélome (IFM)
- Biological signature to predict early relapse in Mantle Cell Lymphoma patients. Results from the MANTLE-FIRST BIO study on behalf of Fondazione Italiana Linfomi (FIL)
- Patient-reported outcomes in research of indolent lymphoma: pitfalls, gaps, and some future directions
- Increased Overall Survival for Subcutaneous Versus Intravenous Daratumumab in Medicare Beneficiaries With Multiple Myeloma
- Treatment Patterns and Outcomes in Patients with TP53-mutated Chronic Lymphocytic Leukemia
- The Association of Allostatic Load with MGUS Incidence and Risk for Progression to Multiple Myeloma
- Effectiveness of high-dose methotrexate for central nervous system relapse prevention in high-risk diffuse large B-cell lymphoma: an updated systematic review and meta-analysis
- Myelodysplastic Syndromes/Neoplasms with Coexisting Autoimmune Disease Are Characterized by Immune Activation and Inferior Survival
- Lineage phenotype and survival in adult mixed-phenotype acute leukemia: a population-based SEER analysis